Key Takeaways from ESMO GI 2025 on Pancreatic Cancer

Promising new therapies are emerging. Daraxonrasib, a KRAS-targeting pill, is in Phase 3 trials after earlier encouraging results and FDA Breakthro...

Read

DiCE Grants — Autumn 2025

DiCE opens Autumn 2025 grants: unrestricted operational support for Full and Associate Members, plus the €5,000 Wolfram Nolte Memorial Award for ...

Read

VOICE: A Life-Changing Training in Cancer Research

Patient advocates joined VOICE in London for a week of immersive learning at Barts Cancer Institute. Exploring cancer biology, research methods, an...

Read

EU-CIP Project Launches to Improve Access to Cancer Information Across Europe

The EU-CIP project launched on 12–13 June in Berlin. This EU-funded initiative will provide clear, reliable cancer information for patients, fami...

Read

Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights

Phase III PANOVA-3 trials show that Tumour-Treating Fields Improve Overall Survival Final data from the Phase 3 PANOVA-3 study of tumour treating f...

Read

Amplifying the Patient Voice: Reflections from the WECAN Academy 2025

DiCE Patient Ambassador Mila Ogalla Toledo shares her experience at the WECAN Academy 2025 in Rome—a three-day training for cancer advocates acro...

Read

AIDA Project Uses Artificial Intelligence to Improve Treatment for a Common Cause of Gastric Cancer

The AIDA project has developed an AI system that helps doctors choose more effective treatments for H. pylori, a major cause of gastric cancer. Bas...

Read

A Decade of Learning and Advocacy: 10th DiCE Masterclass in Barcelona

From 2–4 July 2025, Digestive Cancers Europe celebrated a significant milestone with the 10th edition of the DiCE Masterclass. Held in Barcelona,...

Read

From Plans to Patients: Are EU Cancer Screening and NCD Policies Delivering?

Are EU cancer screening and prevention policies truly reaching patients? We assess the progress of Europe’s Beating Cancer Plan and the SANT Comm...

Read

Putting Early-Onset Colorectal Cancer on the Map: A Milestone Moment at ESMO GI 2025

At ESMO GI 2025, patient advocate Michael Kecht delivered his first international talk, highlighting the alarming rise in early‑onset colorectal ...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.